Insider transactions

EDGAR

SPYRE THERAPEUTICS, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-16.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
94 transactions, 5,243,803 shares
Sum of shares × price per share: 441,932,902.2

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 143

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-01 Filed 2026-10-02Turtle Cameron Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)60089.14
53,484

Derived: shares × price per share. Exact value 53484.00.

551,940Direct (D) Yes
F1, F2, F3
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  • F2 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.63 to $89.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range.
  • F3 Includes 29,078 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
Open filing 0001636282-26-000118 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02Turtle Cameron Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,68390.10
241,738.3

Derived: shares × price per share. Exact value 241738.30.

549,257Direct (D) Yes
F1, F4, F3
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  • F4 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.80 to $90.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  • F3 Includes 29,078 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
Open filing 0001636282-26-000118 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02Turtle Cameron Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,63891.49
241,350.62

Derived: shares × price per share. Exact value 241350.62.

546,619Direct (D) Yes
F1, F5, F3
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  • F5 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.85 to $91.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  • F3 Includes 29,078 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
Open filing 0001636282-26-000118 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02Turtle Cameron Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,98992.31
368,224.59

Derived: shares × price per share. Exact value 368224.59.

542,630Direct (D) Yes
F1, F6, F3
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  • F6 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.87 to $92.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  • F3 Includes 29,078 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
Open filing 0001636282-26-000118 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02Turtle Cameron Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,99093.37
465,916.3

Derived: shares × price per share. Exact value 465916.30.

537,640Direct (D) Yes
F1, F7, F3
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  • F7 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.89 to $93.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  • F3 Includes 29,078 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
Open filing 0001636282-26-000118 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02Turtle Cameron Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)10093.91
9,391

Derived: shares × price per share. Exact value 9391.00.

537,540Direct (D) Yes
F1, F3
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  • F3 Includes 29,078 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
Open filing 0001636282-26-000118 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02Burrows Scott L Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)7,50014.50
108,750

Derived: shares × price per share. Exact value 108750.00.

87,262Direct (D) Yes
F2
  • F2 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
Open filing 0001636282-26-000117 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02Burrows Scott L Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)60089.07
53,442

Derived: shares × price per share. Exact value 53442.00.

86,662Direct (D) Yes
F2, F3
  • F2 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  • F3 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.63 to $89.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000117 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02Burrows Scott L Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,50090.27
135,405

Derived: shares × price per share. Exact value 135405.00.

85,162Direct (D) Yes
F2, F4
  • F2 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  • F4 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.96 to $90.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000117 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02Burrows Scott L Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,10091.92
193,032

Derived: shares × price per share. Exact value 193032.00.

83,062Direct (D) Yes
F2, F5
  • F2 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  • F5 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.41 to $92.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000117 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02Burrows Scott L Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,07192.95
285,449.45

Derived: shares × price per share. Exact value 285449.45.

79,991Direct (D) Yes
F2, F6
  • F2 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  • F6 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.54 to $93.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000117 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02Burrows Scott L Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)22993.57
21,427.53

Derived: shares × price per share. Exact value 21427.53.

79,762Direct (D) Yes
F2, F7, F8
  • F2 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  • F7 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $93.54 to $93.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  • F8 Includes 33,738 RSUs. Each RSU represents a contingent right to receive, upon vesting, one share of the Issuer's common stock. The RSUs vest on September 1, 2027, subject to the Reporting Person's continued employment with the Issuer.
Open filing 0001636282-26-000117 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02Burrows Scott L Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (7,500) — exercise price 14.50
Disposed (D)7,5000—312,357Direct (D) Yes
F2, F9
  • F2 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  • F9 This option represents a right to purchase 404,857 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open filing 0001636282-26-000117 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02King-Jones Heidy Officer: See Remarks
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)28,93314.50
419,528.5

Derived: shares × price per share. Exact value 419528.50.

31,778Direct (D) Yes
F1
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
Open filing 0001636282-26-000119 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02King-Jones Heidy Officer: See Remarks
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)40089.24
35,696

Derived: shares × price per share. Exact value 35696.00.

31,378Direct (D) Yes
F1, F2
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F2 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.63 to $89.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000119 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02King-Jones Heidy Officer: See Remarks
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)16,60590.35
1,500,261.75

Derived: shares × price per share. Exact value 1500261.75.

14,773Direct (D) Yes
F1, F3
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F3 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.96 to $90.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000119 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02King-Jones Heidy Officer: See Remarks
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,22891.35
660,277.8

Derived: shares × price per share. Exact value 660277.80.

7,545Direct (D) Yes
F1, F4
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F4 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.10 to $92.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000119 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02King-Jones Heidy Officer: See Remarks
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,10092.70
194,670

Derived: shares × price per share. Exact value 194670.00.

5,445Direct (D) Yes
F1, F5
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F5 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.12 to $93.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000119 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02King-Jones Heidy Officer: See Remarks
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,60093.46
242,996

Derived: shares × price per share. Exact value 242996.00.

2,845Direct (D) Yes
F1, F6
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F6 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $93.17 to $93.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000119 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02King-Jones Heidy Officer: See Remarks
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (28,933) — exercise price 14.50
Disposed (D)28,9330—482,478Direct (D) Yes
F1, F7
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F7 This option represents the right to purchase 539,810 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open filing 0001636282-26-000119 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-02Burrows Scott L Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)17,50014.50
253,750

Derived: shares × price per share. Exact value 253750.00.

97,262Direct (D) Yes— Open filing 0001636282-26-000117 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-02Burrows Scott L Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)17,50089.89
1,573,075

Derived: shares × price per share. Exact value 1573075.00.

79,762Direct (D) Yes
F1
  • F1 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.00 to $90.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000117 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-02Burrows Scott L Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (17,500) — exercise price 14.50
Disposed (D)17,5000—319,857Direct (D) Yes
F9
  • F9 This option represents a right to purchase 404,857 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open filing 0001636282-26-000117 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-03Burrows Scott L Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)18,23289.35
1,629,029.2

Derived: shares × price per share. Exact value 1629029.20.

79,762Direct (D) Yes
F6, F7
  • F6 The transaction reported reflects the sale of shares of the Issuer's common stock in satisfaction of the Reporting Person's tax liability in connection with the settlement of 33,738 restricted stock units (RSUs). This sale was made to satisfy tax withholding obligations through a sell to cover transaction and does not represent a discretionary trade made by the Reporting Person.
  • F7 Includes 33,738 RSUs. Each RSU represents a contingent right to receive, upon vesting, one share of the Issuer's common stock. The RSUs vest on September 1, 2027, subject to the Reporting Person's continued employment with the Issuer.
Open filing 0001636282-26-000109 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-03King-Jones Heidy Officer: See Remarks
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)40014.50
5,800

Derived: shares × price per share. Exact value 5800.00.

3,245Direct (D) Yes
F1, F2
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F2 Includes 489 shares of common stock acquired by the Reporting Person on August 15, 2024, 495 shares of common stock acquired by the Reporting Person on February 15, 2025, 850 shares of common stock acquired by the Reporting Person on August 15, 2025, 325 shares of common stock acquired by the Reporting Person on December 31, 2025, and 686 shares of common stock acquired by the Reporting Person on June 30, 2026 pursuant to the Issuer's employee stock purchase plan.
Open filing 0001636282-26-000111 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-03King-Jones Heidy Officer: See Remarks
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)40090
36,000

Derived: shares × price per share. Exact value 36000.

2,845Direct (D) Yes
F1, F2
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F2 Includes 489 shares of common stock acquired by the Reporting Person on August 15, 2024, 495 shares of common stock acquired by the Reporting Person on February 15, 2025, 850 shares of common stock acquired by the Reporting Person on August 15, 2025, 325 shares of common stock acquired by the Reporting Person on December 31, 2025, and 686 shares of common stock acquired by the Reporting Person on June 30, 2026 pursuant to the Issuer's employee stock purchase plan.
Open filing 0001636282-26-000111 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-03King-Jones Heidy Officer: See Remarks
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (400) — exercise price 14.50
Disposed (D)4000—511,411Direct (D) Yes
F1, F6
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F6 This option represents the right to purchase 539,810 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open filing 0001636282-26-000111 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03Burrows Scott L Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)7,50014.50
108,750

Derived: shares × price per share. Exact value 108750.00.

105,494Direct (D) Yes
F1
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
Open filing 0001636282-26-000109 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03Burrows Scott L Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)90086.25
77,625

Derived: shares × price per share. Exact value 77625.00.

104,594Direct (D) Yes
F1, F2
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  • F2 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.60 to $86.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000109 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03Burrows Scott L Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,38487.11
381,890.24

Derived: shares × price per share. Exact value 381890.24.

100,210Direct (D) Yes
F1, F3
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  • F3 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.60 to $87.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000109 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03Burrows Scott L Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,01688.03
177,468.48

Derived: shares × price per share. Exact value 177468.48.

98,194Direct (D) Yes
F1, F4
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  • F4 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.64 to $88.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000109 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03Burrows Scott L Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)20089.04
17,808

Derived: shares × price per share. Exact value 17808.00.

97,994Direct (D) Yes
F1, F5
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  • F5 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.69 to $89.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000109 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03Burrows Scott L Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (7,500) — exercise price 14.50
Disposed (D)7,5000—337,357Direct (D) Yes
F1, F8
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  • F8 This option represents a right to purchase 404,857 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open filing 0001636282-26-000109 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03King-Jones Heidy Officer: See Remarks
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)27,99914.50
405,985.5

Derived: shares × price per share. Exact value 405985.50.

30,844Direct (D) Yes
F1, F2
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F2 Includes 489 shares of common stock acquired by the Reporting Person on August 15, 2024, 495 shares of common stock acquired by the Reporting Person on February 15, 2025, 850 shares of common stock acquired by the Reporting Person on August 15, 2025, 325 shares of common stock acquired by the Reporting Person on December 31, 2025, and 686 shares of common stock acquired by the Reporting Person on June 30, 2026 pursuant to the Issuer's employee stock purchase plan.
Open filing 0001636282-26-000111 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03King-Jones Heidy Officer: See Remarks
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,84586.40
418,608

Derived: shares × price per share. Exact value 418608.00.

25,999Direct (D) Yes
F1, F3, F2
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F3 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.71 to $86.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range.
  • F2 Includes 489 shares of common stock acquired by the Reporting Person on August 15, 2024, 495 shares of common stock acquired by the Reporting Person on February 15, 2025, 850 shares of common stock acquired by the Reporting Person on August 15, 2025, 325 shares of common stock acquired by the Reporting Person on December 31, 2025, and 686 shares of common stock acquired by the Reporting Person on June 30, 2026 pursuant to the Issuer's employee stock purchase plan.
Open filing 0001636282-26-000111 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03King-Jones Heidy Officer: See Remarks
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)16,54887.20
1,442,985.6

Derived: shares × price per share. Exact value 1442985.60.

9,451Direct (D) Yes
F1, F4, F2
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F4 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.71 to $87.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  • F2 Includes 489 shares of common stock acquired by the Reporting Person on August 15, 2024, 495 shares of common stock acquired by the Reporting Person on February 15, 2025, 850 shares of common stock acquired by the Reporting Person on August 15, 2025, 325 shares of common stock acquired by the Reporting Person on December 31, 2025, and 686 shares of common stock acquired by the Reporting Person on June 30, 2026 pursuant to the Issuer's employee stock purchase plan.
Open filing 0001636282-26-000111 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03King-Jones Heidy Officer: See Remarks
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)6,20688.17
547,183.02

Derived: shares × price per share. Exact value 547183.02.

3,245Direct (D) Yes
F1, F5, F2
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F5 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.73 to $88.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  • F2 Includes 489 shares of common stock acquired by the Reporting Person on August 15, 2024, 495 shares of common stock acquired by the Reporting Person on February 15, 2025, 850 shares of common stock acquired by the Reporting Person on August 15, 2025, 325 shares of common stock acquired by the Reporting Person on December 31, 2025, and 686 shares of common stock acquired by the Reporting Person on June 30, 2026 pursuant to the Issuer's employee stock purchase plan.
Open filing 0001636282-26-000111 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03King-Jones Heidy Officer: See Remarks
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)40089.38
35,752

Derived: shares × price per share. Exact value 35752.00.

2,845Direct (D) Yes
F1, F2
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F2 Includes 489 shares of common stock acquired by the Reporting Person on August 15, 2024, 495 shares of common stock acquired by the Reporting Person on February 15, 2025, 850 shares of common stock acquired by the Reporting Person on August 15, 2025, 325 shares of common stock acquired by the Reporting Person on December 31, 2025, and 686 shares of common stock acquired by the Reporting Person on June 30, 2026 pursuant to the Issuer's employee stock purchase plan.
Open filing 0001636282-26-000111 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03King-Jones Heidy Officer: See Remarks
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (27,999) — exercise price 14.50
Disposed (D)27,9990—511,811Direct (D) Yes
F1, F6
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F6 This option represents the right to purchase 539,810 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open filing 0001636282-26-000111 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03Turtle Cameron Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,50086.36
215,900

Derived: shares × price per share. Exact value 215900.00.

565,040Direct (D) Yes
F1, F2, F3
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  • F2 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.67 to $86.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range.
  • F3 Includes 43,593 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
Open filing 0001636282-26-000107 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03Turtle Cameron Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8,40087.15
732,060

Derived: shares × price per share. Exact value 732060.00.

556,640Direct (D) Yes
F1, F4, F3
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  • F4 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.67 to $87.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  • F3 Includes 43,593 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
Open filing 0001636282-26-000107 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03Turtle Cameron Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,70088.06
325,822

Derived: shares × price per share. Exact value 325822.00.

552,940Direct (D) Yes
F1, F5, F3
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  • F5 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.68 to $88.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  • F3 Includes 43,593 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
Open filing 0001636282-26-000107 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03Turtle Cameron Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)40089.07
35,628

Derived: shares × price per share. Exact value 35628.00.

552,540Direct (D) Yes
F1, F6, F3
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  • F6 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.69 to $89.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  • F3 Includes 43,593 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
Open filing 0001636282-26-000107 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-10Albers Jeffrey W. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)5,00010.39
51,950

Derived: shares × price per share. Exact value 51950.00.

5,000Direct (D) Yes
F1
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
Open filing 0001636282-26-000102 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-10Albers Jeffrey W. Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)5,000104.47
522,350

Derived: shares × price per share. Exact value 522350.00.

0Direct (D) Yes
F1, F2
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F2 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $103.59 to $105.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000102 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-10Albers Jeffrey W. Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8,000104.38
835,040

Derived: shares × price per share. Exact value 835040.00.

19,360Indirect (I) By Sessions LLCYes
F1, F3
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F3 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $103.52 to $105.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000102 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-10Albers Jeffrey W. Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)10,000104.68
1,046,800

Derived: shares × price per share. Exact value 1046800.00.

9,360Indirect (I) By Sessions LLCYes
F1, F4
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F4 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $103.60 to $106.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open filing 0001636282-26-000102 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-10Albers Jeffrey W. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (5,000) — exercise price 10.39
Disposed (D)5,0000—45,000Direct (D) Yes
F1, F5
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  • F5 This option represents a right to purchase 50,000 shares of the Issuer's common stock, which vest and become exercisable in 36 equal monthly installments beginning on November 22, 2023 until such time as the option is 100% vested, subject to the Reporting Person's continuous service with the Issuer at each vesting date.
Open filing 0001636282-26-000102 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-05Turtle Cameron Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)80093.97
75,176

Derived: shares × price per share. Exact value 75176.00.

581,740Direct (D) Yes
F1, F2, F3
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  • F2 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $93.42 to $94.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range.
  • F3 Includes 58,108 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
Open filing 0001636282-26-000099 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-05Turtle Cameron Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,15795.10
680,630.7

Derived: shares × price per share. Exact value 680630.70.

574,583Direct (D) Yes
F1, F4, F3
  • F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  • F4 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.44 to $95.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  • F3 Includes 58,108 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
Open filing 0001636282-26-000099 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 7,211 filings read, the latest filed 2026-11-13. Prior quarter ending 2026-06-30: 9,150 filings read.

Showing 1–50 of 197

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
FMR LLC Partly reported under another manager13,496,596 SH1,201,601,942 dollarsHigher by 470,409 Prior quarter: 13,026,187Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
BlackRock, Inc. Partly reported under another manager6,779,486 SH603,577,615 dollarsHigher by 272,881 Prior quarter: 6,506,605Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 4,063,789 SH361,799,135 dollarsHigher by 1,733,691 Prior quarter: 2,330,098Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 3,750,793 SH333,933,101 dollarsHigher by 302,112 Prior quarter: 3,448,681Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
STATE STREET CORP Partly reported under another manager3,533,862 SH314,608,605 dollarsHigher by 476,446 Prior quarter: 3,057,416Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager2,552,798 SH236,412,673 dollarsLower by 9,467 Prior quarter: 2,562,265Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Capital World Investors Partly reported under another manager2,364,029 SH210,469,502 dollarsHigher by 48,476 Prior quarter: 2,315,553Open filing 0001422849-26-000169 Filed 2026-11-12 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager1,728,140 SH146,774,789 dollarsHigher by 635,114 Prior quarter: 1,093,026Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager1,435,788 SH142,200,443 dollarsLower by 37,155 Prior quarter: 1,472,943Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
Affinity Asset Advisors, LLC 1,279,134 SH113,881,300 dollarsUnchanged Prior quarter: 1,279,134Open filing 0001011438-26-000687 Filed 2026-11-13 Dispute this row
Remedium Capital Partners, LLC Partly reported under another manager1,160,620 SH103,329,999 dollarsLower by 303,549 Prior quarter: 1,464,169Open filing 0002104501-26-000021 Filed 2026-11-13 Dispute this row
WESTFIELD CAPITAL MANAGEMENT CO LP 883,904 SH78,693,973 dollarsNot in the prior quarter’s filings read Open filing 0001177719-26-000022 Filed 2026-11-12 Dispute this row
Siren, L.L.C. Partly reported under another manager868,598 SH77,331,280 dollarsLower by 100,000 Prior quarter: 968,598Open filing 0002005245-26-000013 Filed 2026-11-12 Dispute this row
UBS Group AG Partly reported under another manager839,946 SH74,780,393 dollarsLower by 3,125 Prior quarter: 843,071Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Capital International Investors Partly reported under another manager630,409 SH56,125,313 dollarsLower by 324,787 Prior quarter: 955,196Open filing 0001562230-26-000136 Filed 2026-11-12 Dispute this row
Clearbridge Investments, LLC 602,519 SH53,642,267 dollarsNot in the prior quarter’s filings read Open filing 0001348883-26-000026 Filed 2026-11-12 Dispute this row
Assenagon Asset Management S.A. 599,224 SH53,348,913 dollarsNot in the prior quarter’s filings read Open filing 0001546007-26-000008 Filed 2026-10-15 Dispute this row
VANGUARD FIDUCIARY TRUST CO 587,439 SH52,299,694 dollarsHigher by 36,050 Prior quarter: 551,389Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
EMERALD ADVISERS, LLC 571,047 SH50,840,314 dollarsHigher by 3,617 Prior quarter: 567,430Open filing 0001104659-26-124249 Filed 2026-11-09 Dispute this row
VICTORY CAPITAL MANAGEMENT INC 548,670 SH48,848,090 dollarsLower by 5,310 Prior quarter: 553,980Open filing 0001040188-26-000051 Filed 2026-11-10 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager544,129 SH48,443,805 dollarsLower by 447,564 Prior quarter: 991,693Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager514,892 SH45,841,020 dollarsNot in the prior quarter’s filings read Open filing 0000748054-26-000008 Filed 2026-11-12 Dispute this row
Pictet Asset Management Holding SA 479,135 SH42,657,389 dollarsLower by 149,003 Prior quarter: 628,138Open filing 0001993888-26-000007 Filed 2026-11-03 Dispute this row
Candriam S.C.A. 448,570 SH40,082,100 dollarsLower by 97,742 Prior quarter: 546,312Open filing 0001537014-26-000009 Filed 2026-11-03 Dispute this row
EMERALD MUTUAL FUND ADVISERS TRUST 366,129 SH32,596,465 dollarsLower by 35,142 Prior quarter: 401,271Open filing 0001104659-26-124247 Filed 2026-11-09 Dispute this row
VOYA INVESTMENT MANAGEMENT LLC Partly reported under another manager348,161 SH30,996,774 dollarsLower by 83,533 Prior quarter: 431,694Open filing 0001068837-26-000006 Filed 2026-11-10 Dispute this row
Nuveen, LLC Partly reported under another manager321,427 SH28,616,646 dollarsHigher by 140,322 Prior quarter: 181,105Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager268,217 SH23,879,360 dollarsHigher by 8,294 Prior quarter: 259,923Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager261,592 SH23,289,535 dollarsHigher by 16,399 Prior quarter: 245,193Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
Fiera Capital Corp Partly reported under another manager255,104 SH22,711,909 dollarsNot in the prior quarter’s filings read Open filing 0001505817-26-000019 Filed 2026-11-06 Dispute this row
EVENTIDE ASSET MANAGEMENT, LLC 252,075 SH22,433,294 dollarsHigher by 50,459 Prior quarter: 201,616Open filing 0001580642-26-007711 Filed 2026-11-13 Dispute this row
Universal- Beteiligungs- und Servicegesellschaft mbH Partly reported under another manager175,769 SH15,648,714 dollarsHigher by 2,846 Prior quarter: 172,923Open filing 0002057170-26-000022 Filed 2026-11-10 Dispute this row
DEUTSCHE BANK AG\ Partly reported under another manager171,199 SH15,241,847 dollarsLower by 3,260 Prior quarter: 174,459Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row
BARCLAYS PLC Partly reported under another manager155,490 SH13,843,274 dollarsHigher by 61,421 Prior quarter: 94,069Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
SILVERARC CAPITAL MANAGEMENT, LLC 151,151 SH13,456,974 dollarsHigher by 91,192 Prior quarter: 59,959Open filing 0001420506-26-002577 Filed 2026-11-12 Dispute this row
Russell Investments Group, Ltd. Partly reported under another manager145,731 SH12,974,557 dollarsHigher by 10,974 Prior quarter: 134,757Open filing 0001193125-26-451241 Filed 2026-11-06 Dispute this row
NEUBERGER BERMAN GROUP LLC 126,496 SH11,261,939 dollarsLower by 54,388 Prior quarter: 180,884Open filing 0001465109-26-000128 Filed 2026-11-13 Dispute this row
MORGAN STANLEY Partly reported under another manager124,938 SH11,123,371 dollarsLower by 375,025 Prior quarter: 499,963Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Swiss National Bank 123,900 SH11,030,817 dollarsHigher by 11,400 Prior quarter: 112,500Open filing 0001582202-26-000008 Filed 2026-11-12 Dispute this row
TD ASSET MANAGEMENT INC 118,654 SH10,052,367 dollarsHigher by 2,664 Prior quarter: 115,990Open filing 0001193125-26-460060 Filed 2026-11-13 Dispute this row
Ensign Peak Advisors, Inc 109,380 SH9,738,101 dollarsLower by 17,240 Prior quarter: 126,620Open filing 0001454984-26-000011 Filed 2026-11-12 Dispute this row
WCM INVESTMENT MANAGEMENT, LLC 106,492 SH9,022,002 dollarsNot in the prior quarter’s filings read Open filing 0001062993-26-005874 Filed 2026-11-10 Dispute this row
MANUFACTURERS LIFE INSURANCE COMPANY, THE Partly reported under another manager101,771 SH9,060,672 dollarsLower by 2,745 Prior quarter: 104,516Open filing 0001145443-26-000111 Filed 2026-11-13 Dispute this row
Empowered Funds, LLC Partly reported under another manager99,816 SH8,886,618 dollarsHigher by 97,085 Prior quarter: 2,731Open filing 0001592828-26-000008 Filed 2026-11-13 Dispute this row
RHUMBLINE ADVISERS 96,966 SH8,632,867 dollarsHigher by 2,203 Prior quarter: 94,763Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row
F/m Investments LLC 95,800 SH8,529,074 dollarsHigher by 3,182 Prior quarter: 92,618Open filing 0001834499-26-000012 Filed 2026-11-13 Dispute this row
Invesco Ltd. Partly reported under another manager95,388 SH8,492,394 dollarsLower by 25,153 Prior quarter: 120,541Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
SEB Asset Management AB 89,950 SH8,008,236 dollarsNot in the prior quarter’s filings read Open filing 0002127509-26-000006 Filed 2026-11-04 Dispute this row
FEDERATED HERMES, INC. Partly reported under another manager88,817 SH7,907,378 dollarsHigher by 2,867 Prior quarter: 85,950Open filing 0001623632-26-001675 Filed 2026-11-12 Dispute this row
Rhenman Partners Asset Management AB 78,600 SH6,997,758 dollarsLower by 40,700 Prior quarter: 119,300Open filing 0001213900-26-118330 Filed 2026-11-12 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • PERCEPTIVE ADVISORS LLC 4,319,496 SH
  • RTW INVESTMENTS, LP 4,251,996 SH
  • Paradigm Biocapital Advisors LP 3,840,778 SH
  • Venrock Adviser, LLC 2,985,448 SH
  • PRICE T ROWE ASSOCIATES INC /MD/ 2,960,855 SH
  • Driehaus Capital Management LLC 2,799,166 SH
  • Jupiter Topco LLC 2,206,936 SH
  • TCG Crossover Management, LLC 1,900,582 SH
  • TANG CAPITAL MANAGEMENT LLC 1,892,200 SH
  • BANK OF AMERICA CORP /DE/ 1,777,854 SH
  • ADAGE CAPITAL PARTNERS GP, L.L.C. 1,722,300 SH
  • WELLINGTON MANAGEMENT GROUP LLP 1,581,505 SH
  • GOLDMAN SACHS GROUP INC 1,478,059 SH
  • Holocene Advisors, LP 1,015,170 SH
  • Polar Capital Holdings Plc 988,009 SH
  • BRAIDWELL LP 879,467 SH
  • Commodore Capital LP 846,786 SH
  • NORTHERN TRUST CORP 674,529 SH
  • Sixth Street Partners Management Company, L.P. 652,958 SH
  • CHARLES SCHWAB INVESTMENT MANAGEMENT INC 652,958 SH
  • UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 522,071 SH
  • SAMLYN CAPITAL, LLC 400,075 SH
  • AMERIPRISE FINANCIAL INC 356,082 SH
  • Integral Health Asset Management, LLC 325,000 SH
  • Woodline Partners LP 306,049 SH
  • JENNISON ASSOCIATES LLC 303,180 SH
  • ADAR1 Capital Management, LLC 283,982 SH
  • Bellevue Group AG 229,931 SH
  • Cormorant Asset Management, LP 225,000 SH
  • SEVEN GRAND MANAGERS, LLC 225,000 SH
  • MILLENNIUM MANAGEMENT LLC 196,712 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 190,400 SH
  • ORBIMED ADVISORS LLC 186,145 SH
  • FRONTIER CAPITAL MANAGEMENT CO LLC 182,931 SH
  • Caption Management, LLC 173,700 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 155,200 SH
  • Balyasny Asset Management L.P. 147,042 SH
  • Soleus Capital Management, L.P. 147,000 SH
  • ARMISTICE CAPITAL, LLC 137,588 SH
  • Blackstone Inc. 120,177 SH
  • STEMPOINT CAPITAL LP 106,926 SH
  • CITADEL ADVISORS LLC 103,100 SH
  • Boxer Capital Management, LLC 100,000 SH
  • ALLIANCEBERNSTEIN L.P. 92,540 SH
  • PRUDENTIAL FINANCIAL INC 87,370 SH
  • Granahan Investment Management, LLC 82,991 SH
  • WELLS FARGO COMPANY/MN 82,506 SH
  • MERCER GLOBAL ADVISORS INC /ADV 71,145 SH
  • B Group, Inc. 70,000 SH
  • Trexquant Investment LP 67,007 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Fairmount Funds Management LLC Common Stock, $0.0001 par value9.199,354,200.0010/07/2026 Filed 2026-10-09SCHEDULE 13D/AAmendment 8Open filing 0001104659-26-115087 Dispute this row
Fairmount Healthcare Fund II L.P. Common Stock, $0.0001 par value9.199,354,200.0010/07/2026 Filed 2026-10-09SCHEDULE 13D/AAmendment 8Open filing 0001104659-26-115087 Dispute this row
Harwin Peter Evan Common Stock, $0.0001 par value9.9910,185,961.0010/07/2026 Filed 2026-10-09SCHEDULE 13D/AAmendment 8Open filing 0001104659-26-115087 Dispute this row
Kiselak Tomas Common Stock, $0.0001 par value9.9910,185,961.0010/07/2026 Filed 2026-10-09SCHEDULE 13D/AAmendment 8Open filing 0001104659-26-115087 Dispute this row
Paradigm BioCapital Advisors LP Common Stock, $0.0001 par value per share5.14,457,450.0009/24/2026 Filed 2026-10-01SCHEDULE 13GOpen filing 0001104659-26-112828 Dispute this row
Paradigm BioCapital Advisors GP LLC Common Stock, $0.0001 par value per share5.14,457,450.0009/24/2026 Filed 2026-10-01SCHEDULE 13GOpen filing 0001104659-26-112828 Dispute this row
Senai Asefaw, M.D. Common Stock, $0.0001 par value per share5.14,457,450.0009/24/2026 Filed 2026-10-01SCHEDULE 13GOpen filing 0001104659-26-112828 Dispute this row
Paradigm BioCapital International Fund Ltd. Common Stock, $0.0001 par value per share4.53,928,646.0009/24/2026 Filed 2026-10-01SCHEDULE 13GOpen filing 0001104659-26-112828 Dispute this row
RTW Investments, LP Common Stock, $0.0001 par value4.84,251,996.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001493215-26-000157 Dispute this row
Roderick Wong Common Stock, $0.0001 par value4.84,251,996.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001493215-26-000157 Dispute this row
Perceptive Advisors LLC Common Stock, $0.0001 Par Value Per Share4.94,319,49606/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-352655 Dispute this row
Joseph Edelman Common Stock, $0.0001 Par Value Per Share4.94,319,49606/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-352655 Dispute this row
Perceptive Life Sciences Master Fund, Ltd. Common Stock, $0.0001 Par Value Per Share4.94,319,49606/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-352655 Dispute this row
Fairmount Funds Management LLC Common Stock, $0.0001 par value9.158,835,440.0006/23/2026 Filed 2026-06-23SCHEDULE 13D/AAmendment 7Open filing 0001104659-26-076961 Dispute this row
Fairmount Healthcare Fund II L.P. Common Stock, $0.0001 par value9.158,835,440.0006/23/2026 Filed 2026-06-23SCHEDULE 13D/AAmendment 7Open filing 0001104659-26-076961 Dispute this row
Peter Evan Harwin Common Stock, $0.0001 par value9.999,667,201.0006/23/2026 Filed 2026-06-23SCHEDULE 13D/AAmendment 7Open filing 0001104659-26-076961 Dispute this row
Tomas Kiselak Common Stock, $0.0001 par value9.999,667,201.0006/23/2026 Filed 2026-06-23SCHEDULE 13D/AAmendment 7Open filing 0001104659-26-076961 Dispute this row
Fairmount Funds Management LLC Common Stock, $0.0001 par value9.098,184,941.0004/16/2026 Filed 2026-04-20SCHEDULE 13D/AAmendment 6Open filing 0001104659-26-045578 Dispute this row
Fairmount Healthcare Fund II L.P. Common Stock, $0.0001 par value9.098,184,941.0004/16/2026 Filed 2026-04-20SCHEDULE 13D/AAmendment 6Open filing 0001104659-26-045578 Dispute this row
Peter Harwin Common Stock, $0.0001 par value9.999,016,702.0004/16/2026 Filed 2026-04-20SCHEDULE 13D/AAmendment 6Open filing 0001104659-26-045578 Dispute this row
Tomas Kiselak Common Stock, $0.0001 par value9.999,016,702.0004/16/2026 Filed 2026-04-20SCHEDULE 13D/AAmendment 6Open filing 0001104659-26-045578 Dispute this row
Perceptive Advisors LLC Common Stock, $0.0001 Par Value Per Share5.04,319,49604/15/2026 Filed 2026-04-22SCHEDULE 13GOpen filing 0001193125-26-170304 Dispute this row
Joseph Edelman Common Stock, $0.0001 Par Value Per Share5.04,319,49604/15/2026 Filed 2026-04-22SCHEDULE 13GOpen filing 0001193125-26-170304 Dispute this row
Perceptive Life Sciences Master Fund, Ltd. Common Stock, $0.0001 Par Value Per Share5.04,319,49604/15/2026 Filed 2026-04-22SCHEDULE 13GOpen filing 0001193125-26-170304 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-27SCHEDULE 13G/AAmendment 1Open filing 0000102909-26-002337 Dispute this row
TANG CAPITAL MANAGEMENT, LLC Common Stock, par value $0.0001 per share2.41,892,200.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-002024 Dispute this row
KEVIN TANG Common Stock, par value $0.0001 per share2.41,892,200.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-002024 Dispute this row
TANG CAPITAL PARTNERS, LP Common Stock, par value $0.0001 per share1.31,012,338.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-002024 Dispute this row
TANG CAPITAL PARTNERS INTERNATIONAL, LP Common Stock, par value $0.0001 per share1.1879,862.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-002024 Dispute this row
TANG CAPITAL PARTNERS III, INC Common Stock, par value $0.0001 per share0.00.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-002024 Dispute this row
TANG CAPITAL PARTNERS IV, INC Common Stock, par value $0.0001 per share0.00.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-002024 Dispute this row
Fairmount Funds Management LLC Common Stock, $0.0001 par value8.997,272,341.0010/15/2025 Filed 2025-10-17SCHEDULE 13D/AAmendment 5Open filing 0001104659-25-100449 Dispute this row
Fairmount Healthcare Fund II L.P. Common Stock, $0.0001 par value8.997,272,341.0010/15/2025 Filed 2025-10-17SCHEDULE 13D/AAmendment 5Open filing 0001104659-25-100449 Dispute this row
Peter Evan Harwin Common Stock, $0.0001 par value9.998,106,882.0010/15/2025 Filed 2025-10-17SCHEDULE 13D/AAmendment 5Open filing 0001104659-25-100449 Dispute this row
Tomas Kiselak Common Stock, $0.0001 par value9.998,106,882.0010/15/2025 Filed 2025-10-17SCHEDULE 13D/AAmendment 5Open filing 0001104659-25-100449 Dispute this row
The Vanguard Group Common Stock5.083,066,58606/30/2025 Filed 2025-07-29SCHEDULE 13GOpen filing 0000932471-25-001050 Dispute this row
BlackRock, Inc. Common Stock6.63,962,63506/30/2025 Filed 2025-07-16SCHEDULE 13G/AAmendment 1Open filing 0002052113-25-002469 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,092,408 filings read, dated 2004-06-14 to 2026-11-13: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
202240,015
2023199,811
2024185,386
2025235,520
2026254,737

Filings made before the SEC required XML are listed, not extracted.

Back to SPYRE THERAPEUTICS, INC.